Research Collaborations
Kalik
Lewin regularly negotiates and assists biotechnology firms in
the acquisition of strategic and operational research and development
relationships, partnerships, alliances and joint ventures with
universities, hospitals, government agencies and multinational
industrial companies. The relationships and the associated agreements
and transactions provide the intellectual capital, proprietary
technologies and technology transfer terms and conditions which
enable the development and commercialization of cutting-edge
biotechnology and life science products.
Technology Licensing
For both proprietary technologies and licensed intellectual
property, the terms and conditions of licensing agreements for
patented processes and products and their underlying technologies
require strategic advice and experienced guidance in establishing
the terms and conditions for the license of technologies
from the inventor or to a strategic partner to allow a growing
biotechnology company to bring its products to market. Kalik
Lewin has the experience crafting these arrangements on behalf
of both inventors and their strategic partners to best serve
the emerging life sciences business in the acquisition of proprietary
technology and the commercialization of biotechnology products.
Clinical Trial Development and Management
Utilizing industry experts as partners and working together
with institutional sponsors such as Johns Hopkins University
and the National Cancer Institute, Kalik Lewin has built a unique
practice advising and assisting clients in the development and
management of clinical trials for both diagnostic and therapeutic
technologies. Using this experience, Kalik Lewin is a strong
partner to guide biotechnology companies through the scientific
and regulatory requirements to allow new technologies and products
to successfully meet clinical standards and proceed to regulatory
approval.
Corporate Organization & Governance
Particular expertise in corporate organization and governance
allows Kalik Lewin to provide specialized counseling to biotechnology
firms on critical issues including entity selection, board of
directors composition, investment negotiation, preferred stock
rights, stock option plans, shareholder and non-competition
agreements and operational financing. This expertise in the
organization and structuring of corporations, limited partnerships
and limited liability companies, particularly under Delaware
corporate law allows the firm to offer sound creative approaches
to the negotiation and drafting of governance agreements including
LLC operating agreements and partnership agreements.
Venture Financing
The firm advises both biotechnology firms and investors interested
in the life sciences industry on both debt and equity-based
venture financing. Kalik Lewin offers a wealth of expertise
in the negotiation and structuring of venture capital transactions,
including preferred stock structures, dividend and liquidation
preferences and unique valuation protection and make-whole mechanisms.
